drugset
drugset / Trial / NCT03134183

24-hour Mifepristone and Buccal Versus Mifepristone and Vaginal Misoprostol for Cervical Preparation for D&E

NCT03134183 ↗

Phase 4 Completed 70 enrolled Virginia Commonwealth University
RandomizedParallel-groupTriple-blindTreatment

Summary

This study aims to compare mifepristone and buccal misoprostol to mifepristone and vaginal misoprostol for cervical preparation for second trimester dilation and evacuation (D\&E).

Timeline

Start
2016-11-19
Primary completion
2017-08-01
Completion
2017-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Misoprostol Other / unclassified 400 ug Intrathecal
Background Mifepristone Small molecule 200 mg Oral

Indications

No indication recorded.